Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
US9062043B2 · kind B2 · utility
3Cited by
3References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2011 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Feb 25, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates in part to molecules having certain biological activities that include, but are not limited to, inhibiting cell proliferation, modulating protein kinase activity and modulating polymerase activity. Molecules of the invention can modulate casein kinase (CK) activity and/or poly(ADP-ribose)polymerase (PARP) activity. The invention also relates in part to methods for using such molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.